Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	benzodiazepine receptor activity	GABRA1 GABRA2 GABRA3	4.79e-05	11	135	3	GO:0008503
GeneOntologyMolecularFunction	GABA-gated chloride ion channel activity	GABRA1 GABRA2 GABRA3	2.29e-04	18	135	3	GO:0022851
GeneOntologyMolecularFunction	GABA-A receptor activity	GABRA1 GABRA2 GABRA3	2.71e-04	19	135	3	GO:0004890
GeneOntologyMolecularFunction	actin binding	XIRP1 CEACAM5 SPATA31A7 CD2AP NEB SPATA31A6 SPATA31A5 MYO3A CCDC88A PLEKHG3 DIAPH2	4.18e-04	479	135	11	GO:0003779
GeneOntologyMolecularFunction	GABA receptor activity	GABRA1 GABRA2 GABRA3	4.24e-04	22	135	3	GO:0016917
GeneOntologyMolecularFunction	cytoskeletal protein binding	KIF13B CACNA1D XIRP1 CEACAM5 NRCAM SPATA31A7 CD2AP NEB SPATA31A6 SPATA31A5 MYO3A CCDC88A PLEKHG3 CCSER2 DIAPH2 KIF14 USH2A KLC1	4.40e-04	1099	135	18	GO:0008092
GeneOntologyMolecularFunction	alpha-1,4-glucosidase activity	MGAM GAA	4.48e-04	5	135	2	GO:0004558
GeneOntologyMolecularFunction	ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential	GABRA1 GABRA2 GABRA3	5.51e-04	24	135	3	GO:0099507
GeneOntologyMolecularFunction	alpha-glucosidase activity	MGAM GAA	9.32e-04	7	135	2	GO:0090599
GeneOntologyCellularComponent	immunoglobulin complex	IGKV1-37 IGKV1-17 IGKV1-16 IGKV1-8 IGLV7-43 IGKV6D-21 IGKV1D-37 IGHV4-61 IGHV4-34	1.93e-06	166	141	9	GO:0019814
GeneOntologyCellularComponent	neuron projection membrane	CACNA1D SLC12A5 USH2A GABRA1 GABRA2 GABRA3	1.95e-05	82	141	6	GO:0032589
GeneOntologyCellularComponent	dendrite membrane	CACNA1D SLC12A5 GABRA1 GABRA2 GABRA3	3.77e-05	56	141	5	GO:0032590
GeneOntologyCellularComponent	presynaptic active zone	CACNA1D ZZEF1 ARFGAP3 EGFLAM ATP2B4 GABRA2 GABRA3	4.87e-05	141	141	7	GO:0048786
GeneOntologyCellularComponent	GABA-A receptor complex	GABRA1 GABRA2 GABRA3	2.69e-04	19	141	3	GO:1902711
GeneOntologyCellularComponent	GABA receptor complex	GABRA1 GABRA2 GABRA3	3.65e-04	21	141	3	GO:1902710
GeneOntologyCellularComponent	leading edge membrane	CACNA1D SLC12A5 FAP USH2A GABRA1 GABRA2 GABRA3	5.67e-04	210	141	7	GO:0031256
Domain	DUF4599	SPATA31A7 SPATA31C2 SPATA31A6 SPATA31A5	1.10e-06	12	131	4	PF15371
Domain	DUF4599	SPATA31A7 SPATA31C2 SPATA31A6 SPATA31A5	1.10e-06	12	131	4	IPR027970
Domain	GABAAa_rcpt	GABRA1 GABRA2 GABRA3	6.64e-06	6	131	3	IPR001390
Domain	Big_2	NUP210L NUP210	4.88e-05	2	131	2	PF02368
Domain	Invasin/intimin_cell_adhesion	NUP210L NUP210	4.88e-05	2	131	2	IPR008964
Domain	BID_2	NUP210L NUP210	4.88e-05	2	131	2	SM00635
Domain	Big_2	NUP210L NUP210	4.88e-05	2	131	2	IPR003343
Domain	LAM_G_DOMAIN	LAMA3 FAT2 EGFLAM USH2A	1.42e-04	38	131	4	PS50025
Domain	Laminin_G_2	LAMA3 FAT2 EGFLAM USH2A	1.74e-04	40	131	4	PF02210
Domain	LamG	LAMA3 FAT2 EGFLAM USH2A	2.52e-04	44	131	4	SM00282
Domain	Glyco_hydro_31_CS	MGAM GAA	2.90e-04	4	131	2	IPR030459
Domain	Gal_mutarotase_N	MGAM GAA	2.90e-04	4	131	2	IPR031727
Domain	NtCtMGAM_N	MGAM GAA	2.90e-04	4	131	2	PF16863
Domain	GLYCOSYL_HYDROL_F31_2	MGAM GAA	4.82e-04	5	131	2	PS00707
Domain	GABAA/Glycine_rcpt	GABRA1 GABRA2 GABRA3	5.39e-04	23	131	3	IPR006028
Domain	Kinesin_assoc	KIF13B KIF14	7.19e-04	6	131	2	PF16183
Domain	Glyco_hydro_31_AS	MGAM GAA	7.19e-04	6	131	2	IPR030458
Domain	Kinesin_assoc	KIF13B KIF14	7.19e-04	6	131	2	IPR032405
Domain	Laminin_G	LAMA3 FAT2 EGFLAM USH2A	7.32e-04	58	131	4	IPR001791
Domain	Glyco_hydro_31	MGAM GAA	1.00e-03	7	131	2	IPR000322
Domain	APC_su10/DOC_dom	MYCBP2 ZZEF1	1.00e-03	7	131	2	IPR004939
Domain	DOC	MYCBP2 ZZEF1	1.00e-03	7	131	2	PS51284
Domain	Glyco_hydro_31	MGAM GAA	1.00e-03	7	131	2	PF01055
Domain	ANAPC10	MYCBP2 ZZEF1	1.00e-03	7	131	2	PF03256
Domain	GLYCOSYL_HYDROL_F31_1	MGAM GAA	1.00e-03	7	131	2	PS00129
Domain	APC10	MYCBP2 ZZEF1	1.00e-03	7	131	2	SM01337
Domain	P_TREFOIL_1	MGAM GAA	1.33e-03	8	131	2	PS00025
Domain	Trefoil	MGAM GAA	1.33e-03	8	131	2	PF00088
Domain	P_trefoil_CS	MGAM GAA	1.33e-03	8	131	2	IPR017957
Domain	HTH_MYB	DMTF1 CDC5L	1.70e-03	9	131	2	PS51294
Domain	P_TREFOIL_2	MGAM GAA	1.70e-03	9	131	2	PS51448
Domain	Myb_dom	DMTF1 CDC5L	1.70e-03	9	131	2	IPR017930
Domain	PD	MGAM GAA	1.70e-03	9	131	2	SM00018
Domain	-	MGAM GAA	2.58e-03	11	131	2	4.10.110.10
Domain	P_trefoil_dom	MGAM GAA	3.08e-03	12	131	2	IPR000519
Domain	-	HSPA14 HSPA9	3.08e-03	12	131	2	2.60.34.10
Domain	HSP70_peptide-bd	HSPA14 HSPA9	3.08e-03	12	131	2	IPR029047
Domain	Heat_shock_70_CS	HSPA14 HSPA9	3.62e-03	13	131	2	IPR018181
Domain	Neurotransmitter_ion_chnl_CS	GABRA1 GABRA2 GABRA3	3.86e-03	45	131	3	IPR018000
Domain	Neur_chan_memb	GABRA1 GABRA2 GABRA3	4.11e-03	46	131	3	PF02932
Domain	Neurotrans-gated_channel_TM	GABRA1 GABRA2 GABRA3	4.37e-03	47	131	3	IPR006029
Domain	-	GABRA1 GABRA2 GABRA3	4.37e-03	47	131	3	2.70.170.10
Domain	Neur_chan_LBD	GABRA1 GABRA2 GABRA3	4.37e-03	47	131	3	PF02931
Domain	NEUROTR_ION_CHANNEL	GABRA1 GABRA2 GABRA3	4.37e-03	47	131	3	PS00236
Domain	Neur_channel	GABRA1 GABRA2 GABRA3	4.37e-03	47	131	3	IPR006201
Domain	Neur_chan_lig-bd	GABRA1 GABRA2 GABRA3	4.37e-03	47	131	3	IPR006202
Domain	-	LAMA3 FAT2 EGFLAM USH2A	4.50e-03	95	131	4	2.60.120.200
Domain	Laminin_N	LAMA3 USH2A	5.49e-03	16	131	2	IPR008211
Domain	LamNT	LAMA3 USH2A	5.49e-03	16	131	2	SM00136
Domain	LAMININ_NTER	LAMA3 USH2A	5.49e-03	16	131	2	PS51117
Domain	Laminin_N	LAMA3 USH2A	5.49e-03	16	131	2	PF00055
Domain	HSP70	HSPA14 HSPA9	5.49e-03	16	131	2	PF00012
Domain	PH	PLEKHS1 PLEKHH1 PLEKHG3 SBF2 BTK CADPS2	5.58e-03	229	131	6	PF00169
Domain	Gal_mutarotase_SF_dom	MGAM GAA	6.20e-03	17	131	2	IPR011013
Domain	HSP70_2	HSPA14 HSPA9	6.20e-03	17	131	2	PS00329
Domain	HSP70_1	HSPA14 HSPA9	6.20e-03	17	131	2	PS00297
Domain	HSP70_3	HSPA14 HSPA9	6.20e-03	17	131	2	PS01036
Domain	-	APBA2 PLEKHS1 PLEKHH1 PLEKHG3 SBF2 BTK CADPS2 ANKS1A	6.37e-03	391	131	8	2.30.29.30
Domain	Hsp_70_fam	HSPA14 HSPA9	6.94e-03	18	131	2	IPR013126
Pathway	REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS	PIK3AP1 IGKV1-17 IGKV1-16 IGLV7-43 BTK IGKV1D-16 IGHV4-34	1.76e-06	86	95	7	M601
Pathway	BIOCARTA_FLUMAZENIL_PATHWAY	GABRA1 GABRA2 GABRA3	2.42e-05	9	95	3	M22034
Pathway	REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION	IGKV1-17 IGKV1-16 IGLV7-43 BTK IGKV1D-16 IGHV4-34	2.43e-05	86	95	6	M27206
Pathway	BIOCARTA_GABA_PATHWAY	GABRA1 GABRA2 GABRA3	3.44e-05	10	95	3	M477
Pathway	BIOCARTA_GABA_PATHWAY	GABRA1 GABRA2 GABRA3	3.44e-05	10	95	3	MM1401
Pathway	REACTOME_CD22_MEDIATED_BCR_REGULATION	IGKV1-17 IGKV1-16 IGLV7-43 IGKV1D-16 IGHV4-34	5.52e-05	61	95	5	M27581
Pathway	REACTOME_FCGR_ACTIVATION	IGKV1-17 IGKV1-16 IGLV7-43 IGKV1D-16 IGHV4-34	9.99e-05	69	95	5	M27108
Pathway	REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA	IGKV1-17 IGKV1-16 IGLV7-43 IGKV1D-16 IGHV4-34	9.99e-05	69	95	5	M27150
Pathway	REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS	IGKV1-17 IGKV1-16 IGLV7-43 IGKV1D-16 IGHV4-34	1.15e-04	71	95	5	M1078
Pathway	REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION	IGKV1-17 IGKV1-16 IGLV7-43 IGKV1D-16 IGHV4-34	1.15e-04	71	95	5	M27203
Pathway	WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION	SLC12A5 GABRA1 GABRA2 GABRA3	1.20e-04	38	95	4	M39854
Pathway	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR	PIK3AP1 IGKV1-17 IGKV1-16 IGLV7-43 BTK IGKV1D-16 IGHV4-34	1.28e-04	166	95	7	M608
Pathway	REACTOME_PARASITE_INFECTION	IGKV1-17 IGKV1-16 IGLV7-43 BTK IGKV1D-16 IGHV4-34	1.31e-04	116	95	6	M29843
Pathway	REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT	IGKV1-17 IGKV1-16 IGLV7-43 IGKV1D-16 IGHV4-34	2.02e-04	80	95	5	M6121
Pathway	REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS	IGKV1-17 IGKV1-16 IGLV7-43 IGKV1D-16 IGHV4-34	2.26e-04	82	95	5	M27110
Pathway	REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION	IGKV1-17 IGKV1-16 IGLV7-43 IGKV1D-16 IGHV4-34	2.99e-04	87	95	5	M27205
Pathway	REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS	IGKV1-17 IGKV1-16 IGLV7-43 BTK IGKV1D-16 IGHV4-34	4.06e-04	143	95	6	M27107
Pathway	REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS	PIK3AP1 BTK IGHV4-61 IGHV4-34	4.40e-04	53	95	4	MM15716
Pathway	REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS	IGKV1-17 IGKV1-16 IGLV7-43 IGKV1D-16 IGHV4-34	4.49e-04	95	95	5	M29842
Pathway	REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS	IGKV1-17 IGKV1-16 IGLV7-43 IGKV1D-16 IGHV4-34	5.18e-04	98	95	5	M27152
Pathway	REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS	IGKV1-17 IGKV1-16 IGLV7-43 BTK IGKV1D-16 IGHV4-34	6.02e-04	154	95	6	M39007
Pathway	REACTOME_COMPLEMENT_CASCADE	IGKV1-17 IGKV1-16 IGLV7-43 IGKV1D-16 IGHV4-34	1.07e-03	115	95	5	M19752
Pathway	WP_GABA_RECEPTOR_SIGNALING	GABRA1 GABRA2 GABRA3	1.16e-03	31	95	3	M39369
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	APBA2 CPD RABL3 CCDC88A ARFGAP3 KIAA1217 CCSER2 TMEM131L TANC1 USP54 ANKS1A	1.55e-08	263	145	11	34702444
Pubmed	Specific GABAA circuits for visual cortical plasticity.	GABRA1 GABRA2 GABRA3	7.10e-08	3	145	3	15017002
Pubmed	Specific subtypes of GABAA receptors mediate phasic and tonic forms of inhibition in hippocampal pyramidal neurons.	GABRA1 GABRA2 GABRA3	7.10e-08	3	145	3	16835366
Pubmed	Analysis of the presence and abundance of GABAA receptors containing two different types of alpha subunits in murine brain using point-mutated alpha subunits.	GABRA1 GABRA2 GABRA3	7.10e-08	3	145	3	15304513
Pubmed	The alpha 1, alpha 2, and alpha 3 subunits of GABAA receptors: comparison in seizure-prone and -resistant mice and during development.	GABRA1 GABRA2 GABRA3	7.10e-08	3	145	3	1356407
Pubmed	Region and layer-specific expression of GABAA receptor isoforms and KCC2 in developing cortex.	SLC12A5 GABRA1 GABRA2 GABRA3	9.35e-08	11	145	4	38894703
Pubmed	The α1, α2, α3, and γ2 subunits of GABAA receptors show characteristic spatial and temporal expression patterns in rhombencephalic structures during normal human brain development.	GABRA1 GABRA2 GABRA3	2.83e-07	4	145	3	26518133
Pubmed	Analgesia and unwanted benzodiazepine effects in point-mutated mice expressing only one benzodiazepine-sensitive GABAA receptor subtype.	GABRA1 GABRA2 GABRA3	2.83e-07	4	145	3	25865415
Pubmed	Molecular and functional diversity of GABA-A receptors in the enteric nervous system of the mouse colon.	GABRA1 GABRA2 GABRA3	2.83e-07	4	145	3	25080596
Pubmed	GABA(A) receptor downregulation in brains of subjects with autism.	GABRA1 GABRA2 GABRA3	2.83e-07	4	145	3	18821008
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	KIF13B NRCAM UACA MYCBP2 SLC12A5 CCDC88A WIZ KIAA1217 DIAPH2 CDC5L CTNND2 CABIN1 PRRC2A ATP2B4 HSPA9 KLC1 ANKS1A	6.11e-07	963	145	17	28671696
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	KIF13B MYCBP2 CD2AP MAP3K20 CCDC88A KCNQ5 PLEKHG3 KIAA1217 CCSER2 KIF14 TANC1 USP54 PAN3 RNF180 KLC1 ANKS1A	6.87e-07	861	145	16	36931259
Pubmed	Itch suppression in mice and dogs by modulation of spinal α2 and α3GABAA receptors.	GABRA1 GABRA2 GABRA3	7.05e-07	5	145	3	30104684
Pubmed	HENA, heterogeneous network-based data set for Alzheimer's disease.	UACA CD2AP APBA2 CCDC88A APEX2 CCSER2 CDC5L	7.60e-07	120	145	7	31413325
Pubmed	Ecm29-mediated proteasomal distribution modulates excitatory GABA responses in the developing brain.	SLC12A5 KLC1 GABRA1 GABRA2	8.48e-07	18	145	4	31910261
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	UACA MYCBP2 CD2AP LAMA3 CPD ATP10A ZNF248 PLEKHH1 YEATS2 KCNQ5 PLEKHG3 KIAA1217 SBF2 NUP210 SEMA6A TANC1 PAN3 PALS2 TET3 ANKS1A FAM149A	1.04e-06	1489	145	21	28611215
Pubmed	Characteristics of the immunoglobulin Vkappa genes, pseudogenes, relics and orphons in the mouse genome.	IGKV1-17 IGKV1-16 IGKV1-8 IGKV6D-21	1.33e-06	20	145	4	10427970
Pubmed	The testis-specific VAD1.3/AEP1 interacts with β-actin and syntaxin 1 and directs peri-nuclear/Golgi expression with bipartite nucleus localization (BNL) sequence.	SPATA31A7 SPATA31A6 SPATA31A5	1.41e-06	6	145	3	20850414
Pubmed	Modelling extracellular domains of GABA-A receptors: subtypes 1, 2, 3, and 5.	GABRA1 GABRA2 GABRA3	1.41e-06	6	145	3	15033447
Pubmed	GABAA receptor signaling in caudal periaqueductal gray regulates maternal aggression and maternal care in mice.	GABRA1 GABRA2 GABRA3	1.41e-06	6	145	3	20457185
Pubmed	Genetic analyses of tattered, an X-linked dominant, developmental mouse mutation.	GATA1 TFE3 BTK	1.41e-06	6	145	3	7613037
Pubmed	Targeted disruption of the spermatid-specific gene Spata31 causes male infertility.	SPATA31A7 SPATA31A6 SPATA31A5	1.41e-06	6	145	3	25930072
Pubmed	Lamina-specific alterations in cortical GABA(A) receptor subunit expression in schizophrenia.	GABRA1 GABRA2 GABRA3	2.45e-06	7	145	3	20843900
Pubmed	Long-term diazepam treatment enhances microglial spine engulfment and impairs cognitive performance via the mitochondrial 18 kDa translocator protein (TSPO).	GABRA1 GABRA2 GABRA3	2.45e-06	7	145	3	35228700
Pubmed	Developmental changes in GABA receptor subunit composition within the gonadotrophin-releasing hormone-1 neuronal system.	GABRA1 GABRA2 GABRA3	2.45e-06	7	145	3	16101898
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	PIK3AP1 MYCBP2 NVL ZNF317 YEATS2 CCDC88A ARFGAP3 KIF14 TMEM131L TANC1 BZW1 USP54 CDC5L ANKS1A	2.59e-06	733	145	14	34672954
Pubmed	gamma-Aminobutyric acidA receptors displaying association of gamma 3-subunits with beta 2/3 and different alpha-subunits exhibit unique pharmacological properties.	GABRA1 GABRA2 GABRA3	3.91e-06	8	145	3	8175718
Pubmed	GABA(A) receptor cell surface number and subunit stability are regulated by the ubiquitin-like protein Plic-1.	GABRA1 GABRA2 GABRA3	3.91e-06	8	145	3	11528422
Pubmed	Inhibitory synapse dysfunction and epileptic susceptibility associated with KIF2A deletion in cortical interneurons.	GABRA1 GABRA2 GABRA3	8.34e-06	10	145	3	36733270
Pubmed	Functional modifications of acid-sensing ion channels by ligand-gated chloride channels.	GABRA1 GABRA2 GABRA3	8.34e-06	10	145	3	21789198
Pubmed	Structure and function of immunoglobulin genes and precursors.	IGLV7-43 IGHV4-61 IGHV4-34	8.34e-06	10	145	3	428562
Pubmed	New insights into the man-mouse comparative map of the X chromosome.	GATA1 TFE3 GABRA3	1.14e-05	11	145	3	8188251
Pubmed	Review: Central non-glucocorticoid inhibitors of the hypothalamo-pituitary-adrenal axis.	GABRA1 GABRA2 GABRA3	1.14e-05	11	145	3	9924185
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	PIK3AP1 ACACB CD2AP CPD CCDC88A ARFGAP3 KIAA1217 KIF14 TANC1 USP54 PAN3 HSPA9 KLC1 ANKS1A	1.44e-05	853	145	14	28718761
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	UACA MYCBP2 MRPL10 NVL CPD RABL3 CCDC88A R3HCC1L NUP210 CCSER2 TMEM131L PKN2 SEMA6A TANC1 CDC5L ATP2B4 HSPA14 HSPA9 KLC1	1.44e-05	1487	145	19	33957083
Pubmed	Chromosomal localization of GABAA receptor subunit genes: relationship to human genetic disease.	GABRA1 GABRA2 GABRA3	1.52e-05	12	145	3	2561974
Pubmed	Differential roles of GABA(A) receptor subtypes in benzodiazepine-induced enhancement of brain-stimulation reward.	GABRA2 GABRA3	1.73e-05	2	145	2	22763624
Pubmed	Linking GABA(A) receptor subunits to alcohol-induced conditioned taste aversion and recovery from acute alcohol intoxication.	GABRA2 GABRA3	1.73e-05	2	145	2	23147414
Pubmed	α2-containing GABAA receptors expressed in hippocampal region CA3 control fast network oscillations.	GABRA1 GABRA2	1.73e-05	2	145	2	23109109
Pubmed	Functional expression of the GABA(A) receptor α2 and α3 subunits at synapses between intercalated medial paracapsular neurons of mouse amygdala.	GABRA2 GABRA3	1.73e-05	2	145	2	22666188
Pubmed	Cloning of cDNA sequences encoding human alpha 2 and alpha 3 gamma-aminobutyric acidA receptor subunits and characterization of the benzodiazepine pharmacology of recombinant alpha 1-, alpha 2-, alpha 3-, and alpha 5-containing human gamma-aminobutyric acidA receptors.	GABRA2 GABRA3	1.73e-05	2	145	2	8391122
Pubmed	GAB(A) receptors present higher affinity and modified subunit composition in spinal motor neurons from a genetic model of amyotrophic lateral sclerosis.	GABRA1 GABRA2	1.73e-05	2	145	2	18973555
Pubmed	Reversal of pathological pain through specific spinal GABAA receptor subtypes.	GABRA2 GABRA3	1.73e-05	2	145	2	18202657
Pubmed	GRP75 mediates endoplasmic reticulum-mitochondria coupling during palmitate-induced pancreatic β-cell apoptosis.	LEPR HSPA9	1.73e-05	2	145	2	34756890
Pubmed	Maintenance of recombinant type A gamma-aminobutyric acid receptor function: role of protein tyrosine phosphorylation and calcineurin.	GABRA1 GABRA3	1.73e-05	2	145	2	9655866
Pubmed	Transient expression of GABAA receptor alpha2 and alpha3 subunits in differentiating cerebellar neurons.	GABRA2 GABRA3	1.73e-05	2	145	2	14766194
Pubmed	Molecular and neuronal substrate for the selective attenuation of anxiety.	GABRA2 GABRA3	1.73e-05	2	145	2	11021797
Pubmed	Consequences of prenatal exposure to diazepam on the respiratory parameters, respiratory network activity and gene expression of alpha1 and alpha2 subunits of GABA(A) receptor in newborn rat.	GABRA1 GABRA2	1.73e-05	2	145	2	18085262
Pubmed	Neural basis of benzodiazepine reward: requirement for α2 containing GABAA receptors in the nucleus accumbens.	GABRA2 GABRA3	1.73e-05	2	145	2	24553732
Pubmed	Quantitative localisation of synaptic and extrasynaptic GABAA receptor subunits on hippocampal pyramidal cells by freeze-fracture replica immunolabelling.	GABRA1 GABRA2	1.73e-05	2	145	2	21073549
Pubmed	Involvement of the K+-Cl- co-transporter KCC2 in the sensitization to morphine-induced hyperlocomotion under chronic treatment with zolpidem in the mesolimbic system.	SLC12A5 GABRA1	1.73e-05	2	145	2	23565710
Pubmed	Altered cortical GABAA receptor composition, physiology, and endocytosis in a mouse model of a human genetic absence epilepsy syndrome.	GABRA1 GABRA3	1.73e-05	2	145	2	23744069
Pubmed	Functional mapping of GABA A receptor subtypes in the amygdala.	GABRA2 GABRA3	1.73e-05	2	145	2	15341600
Pubmed	Testing the silence of mutations: Transcriptomic and behavioral studies of GABA(A) receptor α1 and α2 subunit knock-in mice.	GABRA1 GABRA2	1.73e-05	2	145	2	21056629
Pubmed	Dissecting the role of diazepam-sensitive γ-aminobutyric acid type A receptors in defensive behavioral reactivity to mild threat.	GABRA2 GABRA3	1.73e-05	2	145	2	23067879
Pubmed	The signaling protein GIV/Girdin mediates the Nephrin-dependent insulin secretion of pancreatic islet β cells in response to high glucose.	LEPR CCDC88A	1.73e-05	2	145	2	36822326
Pubmed	Misexpression of the constitutive Rpgr(ex1-19) variant leads to severe photoreceptor degeneration.	SEMA6A RPGR	1.73e-05	2	145	2	21546531
Pubmed	Enrichment of GABAA Receptor α-Subunits on the Axonal Initial Segment Shows Regional Differences.	GABRA2 GABRA3	1.73e-05	2	145	2	26973458
Pubmed	IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes.	IGKV1-17 IGKV1-16 IGLV7-43 IGHV4-61 IGHV4-34	1.82e-05	77	145	5	15608191
Pubmed	Neurotransmitter-mediated action of an antagonist of growth hormone-releasing hormone on anxiolysis in mice.	GABRA1 GABRA2 GABRA3	1.97e-05	13	145	3	22569571
Pubmed	Involvement of neurotransmitters in the action of growth hormone-releasing hormone antagonist on passive avoidance learning.	GABRA1 GABRA2 GABRA3	1.97e-05	13	145	3	22640814
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	MYCBP2 RBBP6 MAP3K20 F5 ATP10A KIF14 CTNND2 CADPS2 PRRC2A	2.22e-05	361	145	9	26167880
Pubmed	Asprosin-neutralizing antibodies as a treatment for metabolic syndrome.	LEPR NNT GABRA2	3.82e-05	16	145	3	33904407
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	KIF13B RAD18 RBBP6 YEATS2 CCDC88A APEX2 KIAA1217 KIF14 TANC1 SLX4 CDCA4	3.86e-05	588	145	11	38580884
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	KIF13B UACA ATP10A TMEM200A FAT2 PLEKHG3 SBF2 NUP210 CDC5L SLX4	4.48e-05	493	145	10	15368895
Pubmed	The effects of the nonselective benzodiazepine lorazepam and the α2 /α3 subunit-selective GABAA receptor modulators AZD7325 and AZD6280 on plasma prolactin levels.	GABRA2 GABRA3	5.16e-05	3	145	2	27128218
Pubmed	Cutting edge: Leptin-induced RORγt expression in CD4+ T cells promotes Th17 responses in systemic lupus erythematosus.	LEPR RORC	5.16e-05	3	145	2	23447682
Pubmed	Gene expression meta-analysis reveals the down-regulation of three GABA receptor subunits in the superior temporal gyrus of patients with schizophrenia.	GABRA1 GABRA2	5.16e-05	3	145	2	32376074
Pubmed	Developmental maturation of synaptic and extrasynaptic GABAA receptors in mouse thalamic ventrobasal neurones.	GABRA1 GABRA2	5.16e-05	3	145	2	18063661
Pubmed	GABRG1 and GABRA2 as independent predictors for alcoholism in two populations.	GABRA1 GABRA2	5.16e-05	3	145	2	18818659
Pubmed	GABAA receptor subunits in the human amygdala and hippocampus: Immunohistochemical distribution of 7 subunits.	GABRA1 GABRA3	5.16e-05	3	145	2	29023704
Pubmed	Variability in the benzodiazepine response of serotonin 5-HT1A receptor null mice displaying anxiety-like phenotype: evidence for genetic modifiers in the 5-HT-mediated regulation of GABA(A) receptors.	GABRA1 GABRA2	5.16e-05	3	145	2	15254090
Pubmed	Candidate genes for alcohol dependence: A genetic association study from India.	GABRA1 GABRA2	5.16e-05	3	145	2	28361821
Pubmed	Transient expression of a GABA receptor subunit during early development is critical for inhibitory synapse maturation and function.	GABRA1 GABRA3	5.16e-05	3	145	2	34433078
Pubmed	Strong genetic evidence for a selective influence of GABAA receptors on a component of the bipolar disorder phenotype.	GABRA1 GABRA2 GABRA3	5.53e-05	18	145	3	19078961
Pubmed	GABA neurotransmitter signaling in the developing mouse lens: dynamic regulation of components and functionality.	GABRA1 GABRA2 GABRA3	5.53e-05	18	145	3	18985723
Pubmed	BDNF regulates spontaneous correlated activity at early developmental stages by increasing synaptogenesis and expression of the K+/Cl- co-transporter KCC2.	SLC12A5 GABRA1 GABRA2	5.53e-05	18	145	3	12588844
Pubmed	Prediction of the coding sequences of unidentified human genes. XVIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	UACA KIAA1586 ZNF317 KIAA1614 CADPS2	6.75e-05	101	145	5	10997877
Pubmed	Early growth response 1 (Egr-1) directly regulates GABAA receptor α2, α4, and θ subunits in the hippocampus.	GABRA1 GABRA2 GABRA3	8.93e-05	21	145	3	25708312
Pubmed	Human transcription factor protein interaction networks.	NEPRO HNF1B RAD18 ACACB INO80C RBBP6 GATA1 MRPL10 TFE3 YEATS2 LIPT1 WIZ USP54 PAN3 CABIN1 PRRC2A SLX4	1.01e-04	1429	145	17	35140242
Pubmed	Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization.	MYCBP2 MAP3K20 TFE3 CDC5L HSPA9 KLC1 ANKS1A	1.03e-04	255	145	7	15324660
Pubmed	Suprachiasmatic to paraventricular nuclei interaction generates normal food searching rhythms in mice.	GABRA1 GABRA2	1.03e-04	4	145	2	36277219
Pubmed	APP modulates KCC2 expression and function in hippocampal GABAergic inhibition.	SLC12A5 GABRA1	1.03e-04	4	145	2	28054918
Pubmed	Rad18 regulates DNA polymerase kappa and is required for recovery from S-phase checkpoint-mediated arrest.	RAD18 POLN	1.03e-04	4	145	2	16611994
Pubmed	Mutation of hepatocyte nuclear factor-1beta inhibits Pkhd1 gene expression and produces renal cysts in mice.	HNF1B PKHD1	1.03e-04	4	145	2	15067314
Pubmed	Effect of immunodeficiency on diabetogenesis in genetically diabetic (db/db) mice.	LEPR BTK	1.03e-04	4	145	2	3553324
Pubmed	Gephyrin is critical for glycine receptor clustering but not for the formation of functional GABAergic synapses in hippocampal neurons.	GABRA1 GABRA2	1.03e-04	4	145	2	14715953
Pubmed	Evolution of immunoglobulin V genes: evidence indicating that recently duplicated human V kappa sequences have diverged by gene conversion.	IGKV1-16 IGKV1D-16	1.03e-04	4	145	2	6402305
Pubmed	Association study between GABA receptor genes and anxiety spectrum disorders.	GABRA2 GABRA3	1.03e-04	4	145	2	19842164
Pubmed	Identification of Xin-repeat proteins as novel ligands of the SH3 domains of nebulin and nebulette and analysis of their interaction during myofibril formation and remodeling.	XIRP1 NEB	1.03e-04	4	145	2	23985323
Pubmed	Convergence of Rad6/Rad18 and Fanconi anemia tumor suppressor pathways upon DNA damage.	RAD18 POLN	1.03e-04	4	145	2	20967207
Pubmed	Altered GABA(A) receptor subunit expression and pharmacology in human Angelman syndrome cortex.	GABRA1 GABRA3	1.03e-04	4	145	2	20692323
Pubmed	Proliferating cell nuclear antigen (PCNA)-binding protein C1orf124 is a regulator of translesion synthesis.	RAD18 CPD SLX4	1.03e-04	22	145	3	22902628
Pubmed	Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.	NRCAM APOH F5 LEPR FAP FAT2 GAA	1.08e-04	257	145	7	16335952
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	MYCBP2 RBBP6 CD2AP YEATS2 WIZ KIF14 PKN2 CDC5L PRRC2A KLC1	1.09e-04	549	145	10	38280479
Pubmed	Defining the membrane proteome of NK cells.	MYCBP2 NVL CPD F5 ARFGAP3 NUP210 KIF14 BZW1 CDC5L NNT PRRC2A ATP2B4 HSPA14 GAA KLC1	1.16e-04	1168	145	15	19946888
Pubmed	Association study of 182 candidate genes in anorexia nervosa.	ACACB RGS19 LEPR GABRA1 GABRA2 GABRA3	1.20e-04	182	145	6	20468064
Pubmed	Majority of cerebrospinal fluid-contacting neurons in the spinal cord of C57Bl/6N mice is present in ectopic position unlike in other studied experimental mice strains and mammalian species.	SPATA31A7 SPATA31A6 SPATA31A5	1.35e-04	24	145	3	32212159
Pubmed	The mouse scurfy (sf) mutation is tightly linked to Gata1 and Tfe3 on the proximal X chromosome.	GATA1 TFE3	1.71e-04	5	145	2	7849405
Pubmed	Role of the hepatocyte nuclear factor-1beta (HNF-1beta) C-terminal domain in Pkhd1 (ARPKD) gene transcription and renal cystogenesis.	HNF1B PKHD1	1.71e-04	5	145	2	15647252
Interaction	SFN interactions	KIF13B MYCBP2 CD2AP MAP3K20 NEB TFE3 CCDC88A KCNQ5 PLEKHG3 CCSER2 KIF14 PKN2 TANC1 USP54 PAN3 KLC1 ANKS1A	3.17e-06	692	133	17	int:SFN
Interaction	RNF43 interactions	APBA2 CPD RABL3 CCDC88A ARFGAP3 KIAA1217 CCSER2 TMEM131L TANC1 BZW1 USP54 HSPA9 ANKS1A	5.16e-06	427	133	13	int:RNF43
Cytoband	2p12	IGKV1-37 IGKV1-17 IGKV1-16 IGKV1-8 IGKV6D-21 IGKV1D-37 IGKV1D-16	1.01e-07	117	145	7	2p12
Cytoband	Ensembl 112 genes in cytogenetic band chr2p11	IGKV1-37 IGKV1-17 IGKV1-16 IGKV1-8 IGKV6D-21 IGKV1D-37 IGKV1D-16	5.63e-06	213	145	7	chr2p11
Cytoband	Ensembl 112 genes in cytogenetic band chr9q12	SPATA31A7 SPATA31A5	2.74e-04	8	145	2	chr9q12
GeneFamily	Immunoglobulin kappa locus at 2p11.2	IGKV1-37 IGKV1-17 IGKV1-16 IGKV1-8 IGKV6D-21 IGKV1D-37 IGKV1D-16	2.46e-07	83	94	7	351
GeneFamily	Gamma-aminobutyric acid type A receptor subunits	GABRA1 GABRA2 GABRA3	1.24e-04	19	94	3	563
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	PLEKHS1 PLEKHH1 PLEKHG3 SBF2 BTK CADPS2	7.20e-04	206	94	6	682
Coexpression	CERVERA_SDHB_TARGETS_2	SLC26A2 MATN2 MAP3K20 IGDCC3 F5 LEPR PKHD1 CADPS2	2.09e-07	115	141	8	M19068
Coexpression	MASSARWEH_TAMOXIFEN_RESISTANCE_UP	RAD18 NVL PLEKHS1 CPD SLC12A5 PITPNM1 KIAA1217 DIAPH2 TMEM131L RORC WDR90 BZW1 USP54 CADPS2 FAM149A	6.27e-07	583	141	15	M17454
ToppCell	PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	HNF1B NRCAM LAMA3 PLEKHH1 CFAP54 NUP210 PKHD1 CTNND2	2.12e-07	190	145	8	625c08a0e5227efc46daa512fd579c3938ff76c7
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-37 IGKV1-17 IGKV1-16 IGKV1-8 IGKV1D-37 IGKV1D-16 IGHV4-61 IGHV4-34	2.49e-07	194	145	8	6ef4aeb8d8e35e4df58ff2a8256caa2113291de9
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-37 IGKV1-17 IGKV1-16 IGKV1-8 IGKV1D-37 IGKV1D-16 IGHV4-61 IGHV4-34	2.59e-07	195	145	8	f3f7f1a77a1edd2b50a8211c76fe289738eb04cf
ToppCell	mild_COVID-19_(asymptomatic)-CD8+_T_naive\|World / disease group, cell group and cell class (v2)	RAD18 NRCAM CTC1 CD2AP APBA2 SLC12A5 ZNF682	6.83e-07	152	145	7	f944743f40ff6ed3a7a096dd53e12d3526c67c4d
ToppCell	droplet-Liver-LIVER_HEP-30m-Myeloid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAK MYCBP2 CD2AP PITPNM1 CCDC88A BTK CCDC158	1.56e-06	172	145	7	3f784aed340b50ddbec3f7dc0a5279180d38a2bb
ToppCell	Control-Lymphoid_P-Plasmablast\|Control / Disease group, lineage and cell class	IGKV1-17 IGKV1-16 IGKV1-8 IGKV1D-37 IGKV1D-16 IGHV4-61 IGHV4-34	1.82e-06	176	145	7	4b4416f342b732d2cc60133838728880326257d8
ToppCell	Control-Lymphoid_P\|Control / Disease group, lineage and cell class	IGKV1-17 IGKV1-16 IGKV1-8 IGKV1D-37 IGKV1D-16 IGHV4-61 IGHV4-34	1.82e-06	176	145	7	d895a6b295cd649273ff80ad7785a3e0ae4c728a
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	IGKV1-17 IGKV1-16 IGKV1-8 IGKV1D-37 IGKV1D-16 IGHV4-61 IGHV4-34	1.89e-06	177	145	7	4c434a7b7cc54cf4dac996bbc3f5124d9ef9a9cd
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	IGKV1-17 IGKV1-16 IGKV1-8 IGKV1D-37 IGKV1D-16 IGHV4-61 IGHV4-34	1.89e-06	177	145	7	d746122bf8d208c3aa4d156e8c12d0a0e555c6e5
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	IGKV1-17 IGKV1-16 IGKV1-8 IGKV1D-37 IGKV1D-16 IGHV4-61 IGHV4-34	1.89e-06	177	145	7	fc40918825b7e1eb6861df59dfca944778a64b98
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	KIF13B KIAA1217 CHSY3 USP54 CADPS2 ZNF682 FAM149A	1.97e-06	178	145	7	f5ed4a6e3eb8056b1be1fb311021710c95bdf888
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGKV1-17 IGKV1-16 IGKV1-8 IGKV1D-37 IGKV1D-16 IGHV4-61 IGHV4-34	2.04e-06	179	145	7	837ed81f18257f444eaeadc4fac89deedd4e3061
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGKV1-17 IGKV1-16 IGKV1-8 IGKV1D-37 IGKV1D-16 IGHV4-61 IGHV4-34	2.04e-06	179	145	7	494febe77c6d4e6a2c6f0928bbf4c84b0301f188
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGKV1-17 IGKV1-16 IGKV1-8 IGKV1D-37 IGKV1D-16 IGHV4-61 IGHV4-34	2.04e-06	179	145	7	b6ee4f41d8fb5f047b7bdd8489dda0a89fc6d43f
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CD2AP LAMA3 KIAA1217 PKHD1 RORC USP54 CADPS2	2.45e-06	184	145	7	42ce855b4f8475a8298192feec785bdc69bc5bb0
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	LAMA3 CCDC88A DIAPH2 PKHD1 SIGLEC11 USH2A TET3	2.63e-06	186	145	7	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	healthy_donor-Lymphocytic-Plasma_cell-IgA_Plasmablast\|healthy_donor / Disease condition, Lineage, Cell class and subclass	IGKV1-17 IGKV1-8 IGKV1D-37 IGKV1D-16 IGHV4-61 IGHV4-34 FAM149A	2.63e-06	186	145	7	e2c050ba02e1f84f0b7258dc92e7ff6ab349ff67
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	HNF1B NRCAM LAMA3 PKHD1 CTNND2 GABRA1 FAM149A	2.92e-06	189	145	7	7659c7bbd58ee959a159294fb8d17317bbcc5681
ToppCell	PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	HNF1B NRCAM LAMA3 MYO3A PKHD1 KIF14 CTNND2	3.24e-06	192	145	7	25378b5e4b0cea8415ff125783511fc25a56fc00
ToppCell	PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	HNF1B NRCAM LAMA3 MYO3A NUP210 PKHD1 CTNND2	3.24e-06	192	145	7	d3634574b2e8d2ded6446969361b70761b331aea
ToppCell	PCW_07-8.5-Epithelial-Epithelial_proliferating\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	HNF1B NRCAM LAMA3 MYO3A NUP210 PKHD1 CTNND2	3.24e-06	192	145	7	1aa5e4d9b32013a3f272561dcb8377f6805706df
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HNF1B NUP210L MYO3A PKHD1 USH2A MUC6 TDRD12	3.36e-06	193	145	7	315840bc48899f3a36d57b19197509de19716e3d
ToppCell	Control-Endothelial-Endothelial\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	UACA LEPR KIAA1217 SBF2 SEMA6A CTNND2 CADPS2	3.36e-06	193	145	7	aff0649c73c634bc6ff0dc7759b4693a9236bf05
ToppCell	Control-Endothelial\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	UACA LEPR KIAA1217 SBF2 SEMA6A CTNND2 CADPS2	3.36e-06	193	145	7	c5f9fe03e64c211d4bcd4959e5b32f14841e336a
ToppCell	Control-Endothelial-Endothelial-Gen_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	UACA LEPR KIAA1217 SBF2 SEMA6A CTNND2 CADPS2	3.36e-06	193	145	7	e1d546165dcc2392f540162206852c4717d7306f
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-37 IGKV1-17 IGKV1-16 IGKV1-8 KIF14 IGHV4-61 IGHV4-34	3.59e-06	195	145	7	df009b18898c10686f75cf72b4ec0eff18f5bb50
ToppCell	Biopsy_IPF-Immune-Plasma_cells\|Biopsy_IPF / Sample group, Lineage and Cell type	IGKV1-37 IGKV1-17 IGKV1-16 IGKV1-8 IGKV1D-16 IGHV4-61 IGHV4-34	3.72e-06	196	145	7	a1b6a8000b86efcb07843998aa3a49bb1f54bcda
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-17 IGKV1-16 IGKV1-8 IGLV7-43 IGKV1D-16 IGHV4-61 IGHV4-34	3.72e-06	196	145	7	fec21383435779bf4c632decd3d29c6ca7baebfb
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CACNA1D NRCAM SLC12A5 KCNQ5 CHSY3 PALS2 GABRA1	3.97e-06	198	145	7	4ca5ff320905ab4ff60ed90a5522227c782142a6
ToppCell	368C-Lymphocytic-Plasma_cell-\|368C / Donor, Lineage, Cell class and subclass (all cells)	IGKV1-37 IGKV1-17 IGKV1-8 NKPD1 IGHV4-61 IGHV4-34	1.53e-05	162	145	6	c21a54310b239d999bbc9d8fb5e8fda16e0bc336
ToppCell	368C-Lymphocytic-Plasma_cell\|368C / Donor, Lineage, Cell class and subclass (all cells)	IGKV1-37 IGKV1-17 IGKV1-8 NKPD1 IGHV4-61 IGHV4-34	1.53e-05	162	145	6	f945688815229c8386cbcbf46deee7df316fa8d3
ToppCell	10x5'-GI_large-bowel\|World / Manually curated celltypes from each tissue	IGKV1-16 IGKV1-8 CEACAM5 CADPS2 IGKV1D-16 IGHV4-61	1.88e-05	168	145	6	1290c909655bc37f6b8bf216d18127a21b99e9c0
ToppCell	metastatic_Brain-B_lymphocytes-Plasma_cells\|metastatic_Brain / Location, Cell class and cell subclass	IGKV1-17 IGKV1-16 IGLV7-43 IGKV6D-21 IGHV4-61 IGHV4-34	2.01e-05	170	145	6	53634da9e9c72f6400639954c286c6e38ea5a188
ToppCell	wk_08-11-Hematologic_Lymphocytic-B\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	PIK3AP1 IGKV1-17 IGKV1-8 IGLV7-43 BTK IGHV4-34	2.14e-05	172	145	6	d1ab8f493b70ec995281f9fb0991f1d3aa7b928f
ToppCell	(2)_Plasma_cells\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	IGKV1-37 IGKV1-17 IGKV1-8 IGKV1D-16 IGHV4-61 IGHV4-34	2.52e-05	177	145	6	ed3c936bb69f9bc7291b4f6cde1d204078117c48
ToppCell	Control\|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LEPR KIAA1217 CHSY3 EGFLAM SEMA6A TANC1	2.52e-05	177	145	6	b8ff6940e31b749776e81ae4f5bbd577dba9749c
ToppCell	droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAK MYCBP2 CD2AP CCDC88A BTK CCDC158	2.52e-05	177	145	6	14fb8d182775dfd0e49aa7e4e12543a85b3b8bd6
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SLC26A2 PLEKHS1 PLEKHH1 KIAA1217 TANC1 USP54	2.68e-05	179	145	6	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	human_hepatoblastoma-Tumor_cells-T6\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	LRRIQ3 NRCAM ATP10A CDKL1 EGFLAM GABRA2	2.68e-05	179	145	6	14fc8ccb6b215063d747643f47d780d2b237eb67
ToppCell	metastatic_Lymph_Node-B_lymphocytes-Plasma_cells\|B_lymphocytes / Location, Cell class and cell subclass	IGKV1-37 IGKV1-16 IGKV1D-37 CADPS2 IGHV4-34 MUC6	2.94e-05	182	145	6	27d1688fdfc570cedd233aa7030bce7d9b604d42
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CHSY3 USP54 PALS2 CADPS2 ZNF682 FAM149A	3.13e-05	184	145	6	102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7
ToppCell	5'-GW_trimst-2-LymphNode-Hematopoietic-B_cells-Pre-B\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGKV1-37 PIK3AP1 RGS19 IGLV7-43 BTK TMEM131L	3.23e-05	185	145	6	0fa7970709dc957dea95fabbd83263a0335babd5
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Adult / Lineage, Cell type, age group and donor	KIAA1217 USP54 PALS2 CADPS2 ZNF682 FAM149A	3.23e-05	185	145	6	673f0c688ae6984bc8027df2da335787924f4137
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	KIAA1217 CHSY3 USP54 CADPS2 ZNF682 FAM149A	3.23e-05	185	145	6	98b8ee42b89d97e4c9db01740e0c193503c68f2c
ToppCell	Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CDKL1 TMEM200A MYO3A KCNQ5 EGFLAM TANC1	3.23e-05	185	145	6	a7dba7db79275884b2a93d8a16f2e0c739e71370
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LAMA3 MYO3A PKHD1 RORC USP54 CADPS2	3.33e-05	186	145	6	4e94158db52df41d71e67b02b9895a358eebee0f
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TMEM200A MYO3A TINAG PKHD1 SEMA6A PALS2	3.33e-05	186	145	6	f28d72b47624b69a580b4429e2be560a26898591
ToppCell	Mild_COVID-19-B_cell-B_cell\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	IGKV1-17 IGKV1-16 IGKV1-8 KCNQ5 IGHV4-61 IGHV4-34	3.33e-05	186	145	6	855a5a00ba2aa1b5c63b8db56d026ddecc546050
ToppCell	Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|World / Lineage, Cell type, age group and donor	KIAA1217 CHSY3 USP54 CADPS2 ZNF682 FAM149A	3.43e-05	187	145	6	81cc8435b2704a9a8287b3f54acaae0f11dd4ac7
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HNF1B LAMA3 PKHD1 RORC USP54 CADPS2	3.43e-05	187	145	6	58d48128547ee3513d0bf7f78e61b76b1c472ca9
ToppCell	368C-Lymphocytic-NK_cells-NK_cell_D3\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	PIK3AP1 KIF13B KIAA1586 TANC1 RPGR ZNF682	3.43e-05	187	145	6	c667fae6440dc98072b584f203d00f0fb1cb2f21
ToppCell	Fetal_29-31_weeks-Mesenchymal-pericyte_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	NRCAM TMEM200A MYO3A KCNQ5 EGFLAM TANC1	3.43e-05	187	145	6	a2bf958ea59c359a265bfa437d59315e1920cdd4
ToppCell	5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NRCAM MATN2 YEATS2 FAP SEMA6A TANC1	3.53e-05	188	145	6	524d1d928c9386acf20e53d31894107dd7290dc7
ToppCell	healthy_donor-Lymphocytic-Plasma_cell\|healthy_donor / Disease condition, Lineage, Cell class and subclass	IGKV1-17 IGKV1-8 IGKV1D-37 IGKV1D-16 IGHV4-61 IGHV4-34	3.53e-05	188	145	6	bd53b0371154cff680226897b61c9809a239d1b6
ToppCell	5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NRCAM MATN2 YEATS2 FAP SEMA6A TANC1	3.53e-05	188	145	6	1b57995d70cf81212e8d46dfaf44dbaf9c7bc4d5
ToppCell	5'-Airway_Nasal-Endothelial-Blood_vessel_EC\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NRCAM MATN2 YEATS2 FAP SEMA6A TANC1	3.53e-05	188	145	6	cd2d1f8e43c252dd8730a5758458ef63e7ffc836
ToppCell	5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NRCAM MATN2 YEATS2 FAP SEMA6A TANC1	3.53e-05	188	145	6	f5a2f324f3f6c5078d57130392d3f1ba74f29094
ToppCell	5'-Airway_Nasal-Endothelial\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NRCAM MATN2 YEATS2 FAP SEMA6A TANC1	3.53e-05	188	145	6	6c9d5e4014f807149328ff4eabd5e86dfe18094d
ToppCell	PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	HNF1B NRCAM LAMA3 NUP210 PKHD1 CTNND2	3.64e-05	189	145	6	5d9da836ce4308b8458bb3be3871a0aca734b6cd
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	UACA KIAA1217 SEMA6A TANC1 CADPS2 ATP2B4	3.64e-05	189	145	6	b6b4da51bc7f2c13a2f940540fdc61027d084835
ToppCell	renal_medulla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	ACACB NRCAM CDKL1 KIAA1217 PKHD1 CADPS2	3.64e-05	189	145	6	830d9cd0dd706bce22eb2416f07b2c31c870a05a
ToppCell	LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ACACB UACA LEPR EGFLAM SEMA6A CTNND2	3.64e-05	189	145	6	e82211b9dc7540e7a183be2cbcfae39fdf503949
ToppCell	LPS_only-Endothelial-Endothelial-Alv_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	UACA KIAA1217 EGFLAM SEMA6A TANC1 CTNND2	3.75e-05	190	145	6	474cbbab8f3b0a6881fa6c92edb78e43999f9ab0
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGKV1-17 IGKV1-16 IGKV1-8 IGKV1D-16 IGHV4-61 IGHV4-34	3.75e-05	190	145	6	79ee6d10dfbb775da149a1104da5823cf63bbb46
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TMEM200A LEPR KCNQ5 DIAPH2 EGFLAM ATP2B4	3.75e-05	190	145	6	7fec459cd2ad12c2923a03d098289337c0a4c1d3
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGKV1-17 IGKV1-16 IGKV1-8 IGKV1D-16 IGHV4-61 IGHV4-34	3.75e-05	190	145	6	18762ce78ed0b206ade19e1c8ff76a2647489f68
ToppCell	5'-Adult-LargeIntestine-Hematopoietic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGKV1-17 IGKV1-16 IGKV1-8 IGKV1D-16 IGHV4-61 IGHV4-34	3.86e-05	191	145	6	d1d30279ed4612b4f62c225d9eabf0b8a7a09d11
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	HNF1B LAMA3 KIAA1217 PKHD1 USP54 CADPS2	3.86e-05	191	145	6	34cc997e4e5c727495f321e6807a84aa124da486
ToppCell	5'-GW_trimst-2-SmallIntestine-Hematopoietic-B_cells-Immature_B\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGKV1-17 IGKV1-16 IGKV1-8 RGS19 BTK IGHV4-34	3.86e-05	191	145	6	8c35fccc4617694eae1e55b1107841ffe7f1bac8
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	UACA KIAA1217 EGFLAM SEMA6A TANC1 CTNND2	3.97e-05	192	145	6	c618ede75dce3988c87a5b8f98d8e94e1dd66efd
ToppCell	renal_papilla_nuclei-Adult_normal_reference\|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	MGAM ACACB NRCAM MATN2 KIAA1217 TANC1	3.97e-05	192	145	6	6c106b91e46eabbe686a52a65a9c94ad9cbe9390
ToppCell	PCW_07-8.5-Epithelial-Epithelial_alveolar-distal\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	HNF1B NRCAM LAMA3 NUP210 PKHD1 CTNND2	3.97e-05	192	145	6	b7c01e12b3e9be960a741b08835f1dfff65d0d47
ToppCell	PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	HNF1B NRCAM CFAP54 PKHD1 CTNND2 FAM149A	3.97e-05	192	145	6	b99f8236ef4ccdc75c02abea381cae6453205f6f
ToppCell	PCW_05-06-Epithelial-Epithelial_proliferating\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	HNF1B LAMA3 MYO3A NUP210 PKHD1 CTNND2	4.09e-05	193	145	6	5f0eba7b1440beb891d94a288f7f18a4e13c3a88
ToppCell	PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	HNF1B LAMA3 APOH NUP210 PKHD1 CTNND2	4.09e-05	193	145	6	ab78fb1603ea6f720ba2d30148fe65dccf271fe1
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	UACA KIAA1217 EGFLAM SEMA6A TANC1 ATP2B4	4.09e-05	193	145	6	a3636c35ed25aabe2f1aba016c9fe125327bbfaf
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-37 IGKV1-17 IGKV1-16 IGKV1-8 IGHV4-61 IGHV4-34	4.09e-05	193	145	6	282b47dae6043eabb1e13d41d91c07b5ec21cd65
ToppCell	LPS_only-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	UACA LEPR KIAA1217 SEMA6A TANC1 CTNND2	4.21e-05	194	145	6	58f069efdefa0366033764446b9d6ffd4a17807e
ToppCell	PCW_07-8.5-Epithelial\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	HNF1B NRCAM LAMA3 NUP210 PKHD1 CTNND2	4.21e-05	194	145	6	f63ceedb88a9abc8644ee94adfd541e7817c1e3a
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	HNF1B CFAP54 PKHD1 CTNND2 GABRA1 FAM149A	4.21e-05	194	145	6	f95c8dc242c9aebcadfe61b1ed033349cb7e5a88
ToppCell	LPS_only-Endothelial-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	UACA LEPR KIAA1217 SEMA6A TANC1 CTNND2	4.21e-05	194	145	6	bfd92ec75facb0ba55c31e5f2e089d983b3d0169
ToppCell	IPF-Multiplet-Multiplet\|IPF / Disease state, Lineage and Cell class	PLEKHS1 CFAP54 KIAA1217 TANC1 USP54 CADPS2	4.33e-05	195	145	6	fce0c29574bb7aab181b9c00feb42681e285d1f2
ToppCell	PCW_05-06-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	HNF1B LAMA3 MYO3A NUP210 PKHD1 CTNND2	4.33e-05	195	145	6	b78db0d929be6b04055805ea5ffecc56c47ba956
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-16 IGKV1-8 IGKV1D-37 IGKV1D-16 IGHV4-61 IGHV4-34	4.33e-05	195	145	6	13f4ee21568fd747608412d33559d10561dbb3c8
ToppCell	Biopsy_Other_PF-Immune-Plasma_cells\|Biopsy_Other_PF / Sample group, Lineage and Cell type	IGKV1-37 IGKV1-16 IGKV1-8 IGKV1D-16 IGHV4-61 IGHV4-34	4.33e-05	195	145	6	d0305c6a68c9e361507b04db94f86873085d49b3
ToppCell	IPF-Multiplet\|IPF / Disease state, Lineage and Cell class	PLEKHS1 CFAP54 KIAA1217 TANC1 USP54 CADPS2	4.33e-05	195	145	6	eacc0449ae6f3ad8002268cd061467684c6fb9a7
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CACNA1D NRCAM SLC12A5 KCNQ5 CHSY3 GABRA1	4.45e-05	196	145	6	676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	UACA MATN2 ATP10A TMEM200A FAP CHSY3	4.45e-05	196	145	6	fa445f4240c521cf04eb2e2f79a5c55fda31209a
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	UACA MATN2 ATP10A TMEM200A FAP CHSY3	4.45e-05	196	145	6	802f61e78a9a1030a86c4a980c398a73cd4d1574
ToppCell	nucseq-Endothelial-Endothelial_Vascular\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	UACA LEPR KIAA1217 SEMA6A RPGR CADPS2	4.45e-05	196	145	6	686533fd3fba8e4df96b9dd1307e870e89db4332
ToppCell	COPD-Endothelial-VE_Capillary_B\|Endothelial / Disease state, Lineage and Cell class	SLC26A2 CPD LEPR KIAA1217 CADPS2 ANKS1A	4.58e-05	197	145	6	30dbc05ea66892d2e18ff375ffa86d1db7bc4083
ToppCell	COVID-19-lung-Capillary_1\|lung / Disease (COVID-19 only), tissue and cell type	UACA LEPR KIAA1217 SEMA6A RPGR CADPS2	4.58e-05	197	145	6	7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-17 IGKV1-16 IGKV1-8 IGKV1D-16 IGHV4-61 IGHV4-34	4.58e-05	197	145	6	9fe1b757f76c2d43d39aa9ac500eaba98723985c
ToppCell	primary_auditory_cortex_(A1C)-Neuronal\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CACNA1D NRCAM SLC12A5 KCNQ5 CHSY3 GABRA1	4.71e-05	198	145	6	6d18b45eda4014759e6dd282d78ffd28df8a6044
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-B-B_cell-B_naive\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-37 IGKV1-8 KCNQ5 IGKV1D-37 IGHV4-61 IGHV4-34	4.71e-05	198	145	6	79c690d21d3420d0bb1a3b3b4ea2c9aa3810a219
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CACNA1D SLC12A5 KCNQ5 CHSY3 PALS2 GABRA1	4.71e-05	198	145	6	0ff30edfd3c133a42e8cb96e1631a1143215f808
ToppCell	kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	UACA MATN2 PKHD1 PKN2 RNF180 CABIN1	4.85e-05	199	145	6	174f6013af6eafa577f84205a62927f2b367fda3
ToppCell	NS-control-d_0-4-Epithelial-Secretory\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	MYCBP2 SLC26A2 CPD PLEKHH1 FAT2 KIAA1217	4.85e-05	199	145	6	32bdfff40fd442b88489c8b0f79af3927a51a03c
ToppCell	control-Epithelial-Secretory\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	MYCBP2 SLC26A2 CPD PLEKHH1 FAT2 KIAA1217	4.85e-05	199	145	6	262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a
ToppCell	Striatum-Neuronal\|Striatum / BrainAtlas - Mouse McCarroll V32	MYCBP2 CDKL1 SLC12A5 KLC1 GABRA1 GABRA2	4.98e-05	200	145	6	c888fd487990cad482a4ca47601cdebc0ca3f3ce
Drug	Zolpidem	GABRA1 GABRA2 GABRA3	1.90e-07	3	132	3	DB00425
Drug	Flumazenil	GABRA1 GABRA2 GABRA3	7.59e-07	4	132	3	DB01205
Drug	Eszopiclone	GABRA1 GABRA2 GABRA3	1.89e-06	5	132	3	DB00402
Drug	Zopiclone	GABRA1 GABRA2 GABRA3	1.89e-06	5	132	3	DB01198
Drug	Lorazepam	GABRA1 GABRA2 GABRA3	1.89e-06	5	132	3	ctd:D008140
Drug	Chlortetracycline hydrochloride [64-72-2]; Up 200; 7.8uM; MCF7; HT_HG-U133A	MAP3K20 APBA2 NEB F5 WIZ SEMA6A CDC5L NNT ATP2B4	2.30e-06	197	132	9	5360_UP
Drug	Meprobamate	GABRA1 GABRA2 GABRA3	3.76e-06	6	132	3	DB00371
Drug	Quazepam	GABRA1 GABRA2 GABRA3	6.55e-06	7	132	3	DB01589
Drug	Adinazolam	GABRA1 GABRA2 GABRA3	1.04e-05	8	132	3	DB00546
Drug	Fludiazepam	GABRA1 GABRA2 GABRA3	1.04e-05	8	132	3	DB01567
Drug	Clotiazepam	GABRA1 GABRA2 GABRA3	1.04e-05	8	132	3	DB01559
Drug	Cinolazepam	GABRA1 GABRA2 GABRA3	1.04e-05	8	132	3	DB01594
Drug	Prazepam	GABRA1 GABRA2 GABRA3	1.04e-05	8	132	3	DB01588
Drug	Estazolam	GABRA1 GABRA2 GABRA3	1.04e-05	8	132	3	DB01215
Drug	Halazepam	GABRA1 GABRA2 GABRA3	1.04e-05	8	132	3	DB00801
Drug	1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane	GABRA1 GABRA2 GABRA3	1.04e-05	8	132	3	ctd:C091518
Drug	Ethchlorvynol	GABRA1 GABRA2 GABRA3	1.56e-05	9	132	3	DB00189
Drug	Diazepam	GABRA1 GABRA2 GABRA3	1.56e-05	9	132	3	DB00829
Drug	tiotidine	GABRA1 GABRA2 GABRA3	1.56e-05	9	132	3	ctd:C023990
Drug	Quinidine hydrochloride monohydrate [6151-40-2]; Down 200; 10.6uM; MCF7; HT_HG-U133A	ACACB CPD NEB WIZ CCSER2 DIAPH2 RPGR CADPS2	1.87e-05	195	132	8	3191_DN
Drug	Pyrazinamide [ 98-96-4]; Up 200; 32.4uM; MCF7; HT_HG-U133A	MAK CEACAM5 ACACB PLEKHS1 WIZ RORC SEMA6A CABIN1	2.16e-05	199	132	8	4962_UP
Drug	Secobarbital	GABRA1 GABRA2 GABRA3	2.22e-05	10	132	3	DB00418
Drug	Chlordiazepoxide	GABRA1 GABRA2 GABRA3	2.22e-05	10	132	3	DB00475
Drug	Metharbital	GABRA1 GABRA2 GABRA3	2.22e-05	10	132	3	DB00463
Drug	Pentobarbital	GABRA1 GABRA2 GABRA3	2.22e-05	10	132	3	DB00312
Drug	Talbutal	GABRA1 GABRA2 GABRA3	2.22e-05	10	132	3	DB00306
Drug	Clobazam	GABRA1 GABRA2 GABRA3	2.22e-05	10	132	3	DB00349
Drug	Butalbital	GABRA1 GABRA2 GABRA3	2.22e-05	10	132	3	DB00241
Drug	Butabarbital	GABRA1 GABRA2 GABRA3	2.22e-05	10	132	3	DB00237
Drug	Bromazepam	GABRA1 GABRA2 GABRA3	2.22e-05	10	132	3	DB01558
Drug	Barbituric acid derivative	GABRA1 GABRA2 GABRA3	2.22e-05	10	132	3	DB01496
Drug	Barbital	GABRA1 GABRA2 GABRA3	2.22e-05	10	132	3	DB01483
Drug	Hexobarbital	GABRA1 GABRA2 GABRA3	2.22e-05	10	132	3	DB01355
Drug	Aprobarbital	GABRA1 GABRA2 GABRA3	2.22e-05	10	132	3	DB01352
Drug	Amobarbital	GABRA1 GABRA2 GABRA3	2.22e-05	10	132	3	DB01351
Drug	Heptabarbital	GABRA1 GABRA2 GABRA3	2.22e-05	10	132	3	DB01354
Drug	Butethal	GABRA1 GABRA2 GABRA3	2.22e-05	10	132	3	DB01353
Drug	Methylphenobarbital	GABRA1 GABRA2 GABRA3	2.22e-05	10	132	3	DB00849
Drug	Oxazepam	GABRA1 GABRA2 GABRA3	2.22e-05	10	132	3	DB00842
Drug	Primidone	GABRA1 GABRA2 GABRA3	2.22e-05	10	132	3	DB00794
Drug	Midazolam	GABRA1 GABRA2 GABRA3	2.22e-05	10	132	3	DB00683
Drug	Flurazepam	GABRA1 GABRA2 GABRA3	2.22e-05	10	132	3	DB00690
Drug	Clonazepam	GABRA1 GABRA2 GABRA3	2.22e-05	10	132	3	DB01068
Drug	Thiopental	GABRA1 GABRA2 GABRA3	3.04e-05	11	132	3	DB00599
Drug	Alprazolam	GABRA1 GABRA2 GABRA3	3.04e-05	11	132	3	DB00404
Drug	Temazepam	GABRA1 GABRA2 GABRA3	3.04e-05	11	132	3	DB00231
Drug	Nitrazepam	GABRA1 GABRA2 GABRA3	3.04e-05	11	132	3	DB01595
Drug	Lorazepam	GABRA1 GABRA2 GABRA3	3.04e-05	11	132	3	DB00186
Drug	Phenobarbital	GABRA1 GABRA2 GABRA3	3.04e-05	11	132	3	DB01174
Drug	Triazolam	GABRA1 GABRA2 GABRA3	3.04e-05	11	132	3	DB00897
Drug	Clorazepate	GABRA1 GABRA2 GABRA3	3.04e-05	11	132	3	DB00628
Drug	AC1O4QHT	MGAM APOH F5	3.04e-05	11	132	3	CID006398429
Drug	FG5P	MGAM PRRC2A GAA	3.04e-05	11	132	3	CID000127486
Drug	Miglitol	MGAM GAA	3.34e-05	2	132	2	DB00491
Drug	deamelin-S	MGAM APOH	3.34e-05	2	132	2	CID000071793
Drug	tempo-maleimide	MGAM PRRC2A GAA	6.62e-05	14	132	3	CID002724304
Drug	acamprosate	CEACAM5 RORC GABRA1 GABRA2 GABRA3	7.10e-05	74	132	5	CID000071158
Drug	premazepam	DIAPH2 GABRA1 GABRA2	8.24e-05	15	132	3	CID000072104
Drug	gaboxadol	SLC12A5 GABRA1 GABRA2 GABRA3	9.26e-05	41	132	4	CID000003448
Drug	Permite C	APOH DIAPH2	9.97e-05	3	132	2	CID006337406
Drug	dihydroxyaflavinine	GABRA1 GABRA2 GABRA3	1.22e-04	17	132	3	CID000156857
Drug	Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A	KIF13B HNF1B CEL APBA2 LEPR PLEKHG3 RORC	1.24e-04	190	132	7	5602_UP
Drug	AC1L1B1W	CACNA1D SLC12A5 GABRA1 GABRA2 GABRA3	1.30e-04	84	132	5	CID000001248
Drug	clorazepate	SEMA6A GABRA1 GABRA2	1.46e-04	18	132	3	CID000002809
Drug	AC1NRBPQ	MGAM MYO3A R3HCC1L NKPD1 POLN KLC1	1.50e-04	137	132	6	CID005288569
Drug	Quipazine dimaleate salt [4774-24-7]; Up 200; 9uM; MCF7; HT_HG-U133A	APBA2 PLEKHS1 CPD F5 CDKL1 WIZ GABRA1	1.50e-04	196	132	7	7240_UP
Drug	Epicatechin-(-) [154-23-4]; Down 200; 13.8uM; MCF7; HT_HG-U133A	MAP3K20 APBA2 OAS3 NEB CCDC88A RORC SEMA6A	1.50e-04	196	132	7	4419_DN
Drug	Midecamycin [35457-80-8]; Down 200; 5uM; PC3; HT_HG-U133A	ACACB CPD CCDC88A WIZ PLEKHG3 TMEM131L NNT	1.50e-04	196	132	7	6745_DN
Drug	delta-aminovaleric acid	CPD F5 GABRA1 GABRA2	1.59e-04	47	132	4	CID000000138
Drug	nocodazole; Down 200; 1uM; MCF7; HG-U133A	DMTF1 OAS3 ZZEF1 NUP210 PKN2 CTNND2 HSPA9	1.59e-04	198	132	7	621_DN
Drug	Nalbuphine hydrochloride [23277-43-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A	NRCAM PLEKHG3 NUP210 CCSER2 DIAPH2 PALS2 PRRC2A	1.59e-04	198	132	7	7177_DN
Drug	Riluzole hydrochloride; Up 200; 14.8uM; MCF7; HT_HG-U133A	MAK PLEKHS1 LEPR MUC6 ZNF682 GABRA2 FAM149A	1.59e-04	198	132	7	4689_UP
Drug	Quinic acid [86-68-0]; Up 200; 19.6uM; HL60; HT_HG-U133A	ACACB RGS19 OAS3 CDKL1 CCDC88A PLEKHG3 CCSER2	1.64e-04	199	132	7	2978_UP
Drug	Trichlorfon [52-68-6]; Up 200; 15.6uM; PC3; HT_HG-U133A	ACACB CTC1 RBBP6 CPD CCDC88A CDC5L NNT	1.64e-04	199	132	7	1797_UP
Drug	Acarbose	MGAM GAA	1.99e-04	4	132	2	DB00284
Drug	etizolam	GABRA2 GABRA3	1.99e-04	4	132	2	ctd:C044610
Drug	magnesium iodide	MGAM SEMA6A	1.99e-04	4	132	2	CID000066322
Drug	tert-butylbicyclo-2-benzoate	GABRA1 GABRA2	1.99e-04	4	132	2	ctd:C046308
Drug	5-(3-aminopropyl)-2'-deoxyuridine	MGAM POLN	1.99e-04	4	132	2	CID003081165
Drug	AC1L9JSY	MGAM CEACAM5	1.99e-04	4	132	2	CID000446552
Drug	Flunitrazepam	GABRA1 GABRA2 GABRA3	2.35e-04	21	132	3	ctd:D005445
Drug	6 mEq	SLC12A5 GABRA1 GABRA2	2.71e-04	22	132	3	CID000126186
Disease	COMM domain-containing protein 1 measurement	IGKV1-17 IGKV1-16	1.96e-05	2	131	2	EFO_0802424
Disease	level of nuclear factor NF-kappa-B p105 subunit in blood serum	IGKV1-17 IGKV1-16	1.96e-05	2	131	2	OBA_2040323
Disease	Respiratory Tract Infections	LEPR RPGR	5.85e-05	3	131	2	C0035243
Disease	Upper Respiratory Infections	LEPR RPGR	5.85e-05	3	131	2	C0041912
Disease	Autistic Disorder	NRCAM KMT2E ATP10A CADPS2 GABRA1 GABRA2 GABRA3	1.72e-04	261	131	7	C0004352
Disease	prolyl endopeptidase FAP measurement	CEL FAP	1.94e-04	5	131	2	EFO_0021856
Disease	cysteine-rich with EGF-like domain protein 1 measurement	RAD18 NUP210 ATP2B4	3.86e-04	32	131	3	EFO_0021870
Disease	venous thromboembolism, response to antineoplastic agent	LRRIQ3 PKHD1 USP54	8.06e-04	41	131	3	EFO_0004286, GO_0097327
Disease	cup-to-disc ratio measurement, optic cup area measurement, optic disc area measurement	MAP3K20 PLEKHG3	8.60e-04	10	131	2	EFO_0006937, EFO_0006939, EFO_0006940
Disease	Retinitis Pigmentosa	MAK SLC37A3 RPGR USH2A	1.21e-03	104	131	4	C0035334
Disease	Maturity onset diabetes mellitus in young	HNF1B CEL	1.72e-03	14	131	2	C0342276
Disease	resting metabolic rate measurement	RBM44 ARFGAP3	2.25e-03	16	131	2	EFO_0008004
Disease	ovulation	CCDC200 PRRC2A	3.18e-03	19	131	2	GO_0030728
Disease	MYELODYSPLASTIC SYNDROME	CTC1 GATA1 SLX4	3.33e-03	67	131	3	C3463824
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	HNF1B TFE3 MYO3A HSPA9	4.35e-03	148	131	4	C0279702
Disease	Retinitis pigmentosa	MAK RPGR USH2A	4.41e-03	74	131	3	cv:C0035334

Protein segments in the cluster

Peptide	Gene	Start	Entry
SLYNSGTVLPTRKLT	CFAP54	1526	Q96N23
LPGQSRYTRANLASK	CDC5L	671	Q99459
QSQGQYSKITFRTPL	EGFLAM	496	Q63HQ2
RKQPAGNYSLSSVLP	ARFGAP3	466	Q9NP61
ATLRVYKPSAGNNSL	APOH	151	P02749
YNLRLLGSSNSPVSA	LINC00269	91	Q8N2A0
LSQGRNQGSTLPLSY	CTC1	51	Q2NKJ3
LKQYSPLLAAFTTQG	BZW1	321	Q7L1Q6
SAGLISRLKYPVSQQ	BTK	366	Q06187
TISPLNTSYRSGENL	CEACAM5	241	P06731
YLGSTQLLSERNPSK	APBA2	376	Q99767
QPSALDQSKRVGYLT	ANKS1A	556	Q92625
TKASNLLRSSGTVYP	CD2AP	396	Q9Y5K6
SSRGQKNLKSYFQPS	APEX2	386	Q9UBZ4
QLSSYPSAALSKLRV	CHAD	206	O15335
PKTAQNLSIFLGSYR	DIAPH2	711	O60879
AQGNKTRLESSYLPS	DEUP1	306	Q05D60
SPYNKGLIRRAISQS	CEL	226	P19835
APNLSSGNVSLKIYS	PIK3AP1	236	Q6ZUJ8
YLLQTSSSQGLPLTL	DMTF1	511	Q9Y222
SQELYATATLQRPGS	CTNND2	376	Q9UQB3
NGISINSAYTSKILP	ATP2B4	506	P23634
TKTYFSRNSPVLLLG	ATG4C	31	Q96DT6
TKALLNNSGPRYKRS	ATP10A	286	O60312
NSLPRTGLQKYPSTS	POLN	501	Q7Z5Q5
SSLPIKKIAGSNYNT	R3HCC1L	471	Q7Z5L2
EYTSPLSSKNGNRIS	RBM44	906	Q6ZP01
VYTPVASRQSLKQGS	RAD18	116	Q9NS91
TNPRYLAAGSSNAVK	RABL3	181	Q5HYI8
SSLLSLYRKGNPDSV	NVL	121	O15381
VLRSPSAGKLTQYTV	ACACB	896	O00763
SPNSYIKLQTNRDGA	NUP210	1301	Q8TEM1
NTSYTSPGLQRLKDS	MUC6	21	Q6W4X9
ALKYSSNRPPIASLS	KIF14	211	Q15058
LLPGTVSSYNLSQLD	IGDCC3	571	Q8IVU1
TISPKAARVGLLQYS	MATN2	686	O00339
KGYTSLSLFLQRPNS	LAMA3	2411	Q16787
SGTQTTAQLKLSPYV	NRCAM	701	Q92823
SILTGSQYVPKSFQR	FAM149A	746	A5PLN7
RSPGIVSTNLPSYQK	SBF2	1686	Q86WG5
SLLKSPYQGIRSNAT	LIPT1	191	Q9Y234
FLQLSTRLPSTNVYG	MGAM	251	O43451
GKPLSYTSSQSCRRN	KCNQ5	91	Q9NR82
PKLLIYSASNLQSGV	IGKV1D-37	66	P0DSN7
LGKSRSYSVEQLQPA	KIAA1614	1021	Q5VZ46
LSISARNSLPKVAYA	GABRA2	296	P47869
SSSGSSPIQYLKRQT	CCDC88A	1636	Q3V6T2
GSTNYNPSLKSRVTI	IGHV4-61	76	A0A0C4DH41
SSLSGPRLLFKSQAN	PNRC2	76	Q9NPJ4
INLTAGQPTSYSLKI	FAT2	626	Q9NYQ8
AYLVTPNGSNKTTRQ	KIAA1586	186	Q9HCI6
LIKYASQSISGVPSR	IGKV6D-21	66	A0A0A0MT36
VFSLSPGTKANYTRL	EVI2A	21	P22794
VLATQLNSLPGLTYS	KMT2E	766	Q8IZD2
YFLLPAGLSKNTSNS	LEPR	46	P48357
LSISARNSLPKVAYA	GABRA3	321	P34903
LSISARNSLPKVAYA	GABRA1	296	P14867
TNPNNTFYATKRLIG	HSPA9	111	P38646
PGQAPRALIYSTSNK	IGLV7-43	61	P04211
NSPKVYLLIGSRNNT	OLFML1	171	Q6UWY5
SRNIGSNYPEKLSAR	RBBP6	891	Q7Z6E9
PNRIQKSSNFGYITS	PAN3	491	Q58A45
SGLLANYTDPQSKLR	INO80C	146	Q6PI98
NISGSVTLKILPSYR	PALS2	196	Q9NZW5
TLLGRTSYSSINTPK	CCSER2	156	Q9H7U1
NSAAYSSPKLRGTLP	GATA1	181	P15976
CQSSPIRNTGYSQLK	CCDC200	146	A0A1B0GVQ3
SYTEKRLPILSSQAG	CABIN1	1406	Q9Y6J0
TSKLQYLPQLTGSSI	CDKL1	321	Q00532
PNITRLYSLGKSVES	CPD	521	O75976
KELGRVILYPTSNSS	CADPS2	441	Q86UW7
SGRTYNPTAKNLNIV	MAK	586	P20794
LQLSTSLPSQYITGL	GAA	246	P10253
NQSRSSSPTQYGLTK	MAP3K20	631	Q9NYL2
LLIYAASTLQSGVPS	IGKV1-8	66	A0A0C4DH67
PKSLIYAASSLQSGV	IGKV1-16	66	P04430
PKRLIYAASSLQSGV	IGKV1-17	66	P01599
PKLLIYSASNLQSGV	IGKV1-37	66	A0A075B6S9
PGYTSNSSLKPRLLQ	CCDC158	851	Q5M9N0
YPAKNTTIALQAGLR	CACNA1D	1631	Q01668
PTVTTTLKNLGALYR	KLC1	461	Q07866
ARALASSLSSNPYVK	LRRC74B	96	Q6ZQY2
QPKLYTAQGRTLSAF	NUP210L	1386	Q5VU65
GTSFLNPVIYTLKNT	OR4C16	276	Q8NGL9
LSGLPLQSSKNSYSF	RNF180	266	Q86T96
VSSLLSGLANYTNLP	SLC12A5	81	Q9H2X9
LGRSSSDPQAQKYIA	HSPA14	71	Q0VDF9
SSGTKPNPQVYSRLL	OAS3	556	Q9Y6K5
GSTNYNPSLKSRVTI	IGHV4-34	81	P06331
SSPPNKLSGVRYSQQ	HNF1B	341	P35680
KTSGTLISFIYPAQN	NNT	146	Q13423
LPYSSLTSGNVLQRT	RPGR	391	Q92834
SRQDLIPSYSLGSNK	KIF13B	1391	Q9NQT8
PRKSNPVLIYNGSST	USH2A	4681	O75445
TYRALLLQGPSQSSS	RGS19	201	P49795
KPLTYSLTGSTQQSR	SPATA31C2	771	B4DYI2
RISTEGSAKQLPNAY	TMEM131L	191	A2VDJ0
PRNNSIGESLSSQYK	TMEM200A	346	Q86VY9
IIVGSNYSSPSNISK	F5	771	P12259
FSVYSVLGNKPATRQ	NKPD1	91	Q17RQ9
KPLTYSLTGSTQQSR	SPATA31A6	921	Q5VVP1
SLSYIPKGLVRNSIS	PLEKHG3	741	A1L390
VLQTGACYKSLPSRN	TDRD12	476	Q587J7
RTDLYPNSKQLLNSG	NEPRO	496	Q6NW34
PLTYSLTGSIQQSRS	SPATA31A7	926	Q8IWB4
LNSRLKATPSTYSGV	PRRC2A	2086	P48634
LVQSALFKGPITSYS	KIAA1217	576	Q5T5P2
SSVPSSYIRNLQEGL	TANC1	1481	Q9C0D5
QLLYRLPTSDGSASK	MYCBP2	1381	O75592
TLASTPYSLQLGRNK	WIZ	536	O95785
NTSSFKTGNLIYIRP	PKHD1	3726	P08F94
NQYSTLSKPAALTGT	PKN2	316	Q16513
CQTLASQTYKPSRAG	SLX4	1626	Q8IY92
LAGLKTVSSYSLQRQ	CDCA4	21	Q9BXL8
RSLNSSKPLYLGQTG	CHSY3	276	Q70JA7
KSVNASNYGLSPDRQ	FAP	96	Q12884
AALPLLATSSSRYQG	PITPNM1	516	O00562
ELSLGNKRTLFYSSP	PLEKHS1	141	Q5SXH7
RISCSPKTRISNNYG	ZNF321P	126	Q8N8H1
RGSVSAANYIQLPKS	WDR90	46	Q96KV7
LLKASGSGPSYSNNL	RORC	176	P51449
QYLSTTLGPKLASQA	TFE3	201	P19532
LSRQGFINYSKLPSL	MRPL10	186	Q7Z7H8
LIGYSRSPNDKSINA	SLC37A3	371	Q8NCC5
PLTYSLTGSIQQSRS	SPATA31A5	926	Q5VU36
TSQAKYLLGLNLPRT	SLC26A2	266	P50443
QPSLNAYNSLTRSGL	SEMA6A	986	Q9H2E6
NYRNLVSLGLTVSKP	ZNF682	36	O95780
QELTDTLRKYGNPTS	TET3	941	O43151
PVYTALKGRATQISN	PLEKHH1	471	Q9ULM0
LTYTSGNPTKRQSQL	UACA	1341	Q9BZF9
RGKSLTQNSAPSRSY	ZNF26	131	P17031
AAISLAINYPNKATR	ZZEF1	2941	O43149
NYRNLVSLGLSFTKP	ZNF354B	46	Q96LW1
IAIQSKGRYTANLSP	TINAG	256	Q9UJW2
KGRYTANLSPQNLIS	TINAG	261	Q9UJW2
ALTAYSLQPRLTSKA	XIRP1	906	Q702N8
SNLTSLGYQVGKPSL	ZNF317	91	Q96PQ6
GSLNKDPSYSLQVQR	SIGLEC11	26	Q96RL6
KTFNLGTDPVSLRNY	ZNF248	121	Q8NDW4
ANLPPGTKLYLTTNS	YEATS2	751	Q9ULM3
LTYTATLPERSKGLQ	USP54	1566	Q70EL1
PKSLIYAASSLQSGV	IGKV1D-16	66	P01601
LPIYTSGSLKNNAVL	LRRIQ3	356	A6PVS8
IALNPFQSLGLYSTK	MYO3A	376	Q8NEV4
SSNLYKTSLRTLPTG	NEB	4946	P20929